Authors: Cairncross, G Swinnen, L Bayer, R Rosenfeld, S Salzman, D Paleologos, N Kaminer, L Forsyth, P Stewart, D Peterson, K Hu, W Macdonald, D Ramsay, D Smith, A

Citation: G. Cairncross et al., Myeloablative chemotherapy for recurrent aggressive oligodendroglioma, NEURO-ONCOL, 2(2), 2000, pp. 114-119

Authors: Perkins, J Kaminer, L Kruskall, M Cannon, M Uhl, L Dzik, W Silver, H O'Neill, M Popovsky, M King, K Ness, P AuBuchon, J Shapiro, A Yomtovian, R Petz, LD

Citation: J. Perkins et al., Should the FDA mandate that autologous units drawn and transfused within asingle institution be tested for markers of infectious disease?, TRANSFUSION, 40(6), 2000, pp. 752-754

Authors: Bennett, CL Stinson, TJ Tallman, MS Stadtmauer, EA Marsh, RW Friedenberg, W Lazarus, HM Kaminer, L Golub, RM Rowe, JM

Citation: Cl. Bennett et al., Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia, ANN ONCOL, 10(2), 1999, pp. 177-182